During the past decade, ACRC Trials conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ACRC Trials" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "ModernaTX, Inc." with 2 trials sponsored, "AOBiome LLC" with 1 trials sponsored, "Actavis Inc." with 1 trials sponsored and "Biota Scientific Management Pty Ltd" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ACRC Trials" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "ACRC Trials" are "Atopic Dermatitis" (2 trials), "Influenza" (2 trials), "Actinic Keratosis" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "ACRC Trials" in a lesser frequency.

Most popular intervention types in "ACRC Trials" are "Drug" (12 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "40 mg Laninamivir Octanoate" (1 trials), "80 mg Laninamivir Octanoate" (1 trials), "B244" (1 trials) and "Baloxavir Marboxil" (1 trials). Other intervention names were less common.

The vast majority of trials in "ACRC Trials" are 16 trials for "All" genders.

Currently, there are NaN active trials in "ACRC Trials". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in ACRC Trials, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ACRC Trials, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".